Chronic necrotizing pulmonary aspergillosis in a patient treated with a tumor necrosis factor-α inhibitor

Medicine and Dentistry

• TNF Inhibitor 100%
• Lung Aspergillosis 100%
• Ankylosing Spondylitis 66%
• Etanercept 66%
• Tumor Necrosis Factor 33%
• Inflammatory Disorder 33%
• Inflammatory Cytokine 33%
• Rheumatoid Arthritis 33%
• Crohn's Disease 33%
• Infectious Complication 33%
• Aspergillosis 33%
• Autoimmune Disease 33%
• Immunosuppressive Drug 33%
• Inflammatory Arthritis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor Inhibitor 100%
• Lung Aspergillosis 100%
• Ankylosing Spondylitis 66%
• Etanercept 66%
• Tumor Necrosis Factor 33%
• Cytokine 33%
• Rheumatoid Arthritis 33%
• Immunosuppressive Agent 33%
• Infectious Complication 33%
• Autoimmune Disease 33%
• Crohn's Disease 33%
• Aspergillosis 33%
• Inflammatory Arthritis 33%

Immunology and Microbiology

• TNF Inhibitor 100%
• Etanercept 66%
• Ankylosing Spondylitis 66%
• Inflammatory Arthritis 33%
• Immunosuppressive Drug 33%
• Inflammatory Disorder 33%
• Tumor Necrosis Factor 33%
• Proinflammatory Cytokine 33%
• Autoimmune Disease 33%
• Aspergillus 33%
• Crohn's Disease 33%